Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

Oneness Biotech Co Ltd develops botanical new drugs and several biological-active new chemical entities that are purified and molecularly modified from these botanical sources.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/oneness-biotech-co-ltd" target="_blank" data-smartkarma-citation="entities:6357:1" rel="noopener">Oneness Biotech (4743 TT)</a> entered into an exclusive agreement with <a href="https://www.smartkarma.com/entities/china-resources-dubl-crne-phrmctl-co-ltd" target="_blank" data-smartkarma-citation="entities:16578:1" rel="noopener">China Resources Dubl Crne Phrmctl (600062 CH)</a> for commercialization of Fespixon in China, Hong Kong, and Macau.</li>
<li>Fespixon is approved in China as the first new drug for diabetic foot ulcer. Inclusion of the drug in NRDL is the next important milestone.</li>
<li>During 1H24, Oneness Biotech reported revenue of NT$57M, up 36% YoY. With expanding scale of operation, gross profit margin is improving (1Q24: 62.5% vs. 1Q23: 47.9%). Net loss is decreasing.</li>
</ul>



Oneness Biotech (4743 TT) entered into an exclusive agreement with China Resources Dubl Crne Phrmctl (600062 CH) for commercialization of Fespixon in China, Hong Kong, and Macau.
Fespixon is approved in China as the first new drug for diabetic foot ulcer. Inclusion of the drug in NRDL is the next important milestone.
During 1H24, Oneness Biotech reported revenue of NT$57M, up 36% YoY. With expanding scale of operation, gross profit margin is improving (1Q24: 62.5% vs. 1Q23: 47.9%). Net loss is decreasing.


Oneness Biotech (4743 TT): Marketing Progress of Fespixon in China Opens a New Revenue Stream

Equity, Bottom-up Analyst, Investics Research

Sameer Taneja

Equity, Bottom-up Analyst

Investics Research

It is important to note that the information provided by Investics Research is based on publicly available data and own knowledge, which has been gathered and analyzed from a variety of sources. While every effort has been made to ensure the accuracy and completeness of the information provided, it is not guaranteed to be free from errors or omissions. All forecasts and estimates are based on information that has been obtained from public sources that are considered to be reliable. The sources include but are not limited to, company announcements, exchange filings, presentations, etc. Investics does not guarantee the accuracy and completeness of the forecasts, estimates, and/or other information.

Equity Bottom-up Research

Mongolian Mining Corporation produces coking coal.  The Company operates the Ukhaa Khudag mine in Mongolia.

<ul>
<li>Following our insight, <a href="https://www.smartkarma.com/insights/mongolia-mining-corp-975-hk-play-on-coking-coal-price-with-growth-optionality" target="_blank" rel="noopener">Mongolia Mining Corp (975 HK): Play on Coking Coal Price With Growth Optionality, </a><a href="https://www.smartkarma.com/entities/mongolian-mining-corp" target="_blank" data-smartkarma-citation="entities:4382:1" rel="noopener">Mongolian Mining (975 HK)</a><a href="https://www.smartkarma.com/insights/mongolia-mining-corp-975-hk-play-on-coking-coal-price-with-growth-optionality" target="_blank" rel="noopener"> </a>has released its <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0722/2024072200375.pdf" target="_blank" rel="noopener">Q2 2024 operational numbers</a>. </li>
<li>For Q2, the sales of coking coal products increased by 47% YoY and for H1 by 25% YoY. HCC was only 63% of the product mix (vs 87% in H1FY23).</li>
<li>Based on our numbers, the stock trades at 5.6x FY24 PE and 2.6x EV-EBITDA. We await the H1 FY23 results and clarity on the dividend catalyst in August. </li>
</ul>


Following our insight, Mongolia Mining Corp (975 HK): Play on Coking Coal Price With Growth Optionality, Mongolian Mining (975 HK) has released its Q2 2024 operational numbers. 
For Q2, the sales of coking coal products increased by 47% YoY and for H1 by 25% YoY. HCC was only 63% of the product mix (vs 87% in H1FY23).
Based on our numbers, the stock trades at 5.6x FY24 PE and 2.6x EV-EBITDA. We await the H1 FY23 results and clarity on the dividend catalyst in August. 


Mongolian Mining (975 HK): Q2 2024 Production Impressive, Good Set Up for H1

New Zealand Professional Investment Services Firm, Forsyth Barr

Forsyth Barr

New Zealand Professional Investment Services Firm

We are proud to be a New Zealand owned firm, with 21 offices throughout the country and over 300 employees. We assist personal, institutional and corporate clients providing a full range of investment services.

Forsyth Barr is a foundation New Zealand Exchange firm (NZX) and accredited market participant. We have been confirmed by the Financial Markets Authority as a Qualifying Financial Entity (QFE).

Research is the cornerstone of our advice. We have one of New Zealand's leading teams of analysts. Our global affiliations ensure comprehensive research coverage of all major investment markets.

Arvida Group Ltd owns and operates senior care living facilities in New Zealand.

<ul><li>Arvida Group's (ARV) board has unanimously recommended a NZ$1.70 per share takeover bid from Stonepeak, a US based infrastructure and real assets investor.</li><li>The bid represents a ~+65% premium to its previous close, ~0.83x last reported net tangible assets (NTA; NZ$2.05) and on 24 month forward consensus estimates ~18x EV/Annuity EBITDA and ~24x annuity PE. </li><li>Stonepeak has completed its due diligence on ARV and the bid is now conditional on regulatory and shareholder approvals. </li></ul>

Arvida Group's (ARV) board has unanimously recommended a NZ$1.70 per share takeover bid from Stonepeak, a US based infrastructure and real assets investor.The bid represents a ~+65% premium to its previous close, ~0.83x last reported net tangible assets (NTA; NZ$2.05) and on 24 month forward consensus estimates ~18x EV/Annuity EBITDA and ~24x annuity PE. Stonepeak has completed its due diligence on ARV and the bid is now conditional on regulatory and shareholder approvals. 

Contact Energy Limited is a diversified and integrated energy company which focuses on the generation of electricity and the sale of electricity and gas in New Zealand.

<ul><li>Contact Energy (CEN) has had a steady end to FY24, with Tauhara commissioning volumes helping to offset below average hydro generation.</li><li>We calculate FY24 EBITDAF was NZ$662m (after market–making losses), up +NZ$116m on FY23.</li><li>With hydro conditions continuing to be challenging, short-term earnings risk is to the downside, but rising ASX futures prices will help lift medium-term earnings.</li></ul>

Contact Energy (CEN) has had a steady end to FY24, with Tauhara commissioning volumes helping to offset below average hydro generation.We calculate FY24 EBITDAF was NZ$662m (after market–making losses), up +NZ$116m on FY23.With hydro conditions continuing to be challenging, short-term earnings risk is to the downside, but rising ASX futures prices will help lift medium-term earnings.

Contact Energy - Steady End to FY24 - June '24 Operating Stats

Covering the Mexican Economy, Actinver Research

Actinver

Covering the Mexican Economy

Actinver Research

Actinver is a mexican leading financial group, that generates well being for individuals and companies through advisory services that provides investment management to maintain and grow their wealth.

Consorcio ARA SAB de CV and its subsidiaries design and construct entry-level and middle-income residential housing developments throughout Mexico.  The Company also operates as a contractor for non-affiliated clients in the construction, promotion, and marketing of commercial and industrial projects.

<ul>
<li>The housing sector in Mexico has solid fundamentals, with attractive growth expectations for listed developers considering their healthy financial position and access to financing sources.</li>
<li>As a result, these companies are poised to capture the increased demand that the housing deficit generates during the coming years.</li>
<li>Since the start of the bankruptcy processes of the three largest housing developers (GEO, HOMEX, and URBI) in 2014, housing production has maintained a downward trend.</li>
</ul>


The housing sector in Mexico has solid fundamentals, with attractive growth expectations for listed developers considering their healthy financial position and access to financing sources.
As a result, these companies are poised to capture the increased demand that the housing deficit generates during the coming years.
Since the start of the bankruptcy processes of the three largest housing developers (GEO, HOMEX, and URBI) in 2014, housing production has maintained a downward trend.


Actinver Research - Housing Sector : Building a More Profitable Future (Sector Update)

Small Cap Longs
Mighty oaks from tiny acorns grow

Oneness Biotech (4743 TT): Marketing Progress of Fespixon in China Opens a New Revenue Stream

Oneness Biotech partners with CR Double Crane for exclusive commercialization of Fespixon in China, Hong Kong, and Macau. Fespixon is approved in...

Tina Banerjee

Mongolian Mining (975 HK): Q2 2024 Production Impressive, Good Set Up for H1

We provide an update on Mongolian Mining Corp's (975 HK) operational numbers for Q2/H1 FY24 and highlight the catalysts we await in their H1FY24...

Sameer Taneja

Arvida Group - Takeover Offer Returns

Arvida Group's (ARV) board has unanimously recommended a NZ$1.70 per share takeover bid from Stonepeak, a US based infrastructure and real assets...

Forsyth Barr

Contact Energy - Steady End to FY24 - June '24 Operating Stats

Contact Energy (CEN) has had a steady end to FY24, with Tauhara commissioning volumes helping to offset below average hydro generation.

Forsyth Barr

Actinver Research - Housing Sector : Building a More Profitable Future (Sector Update)

The housing sector in Mexico has solid fundamentals, with attractive growth expectations for listed developers considering their healthy financial...

Actinver

Oneness Biotech (4743 TT): Marketing Progress of Fespixon in China Opens a New Revenue Stream

​Oneness Biotech partners with CR Double Crane for exclusive commercialization of Fespixon in China, Hong Kong, and Macau. Fespixon is approved in...

Tina Banerjee

Mongolian Mining (975 HK): Q2 2024 Production Impressive, Good Set Up for H1

We provide an update on Mongolian Mining Corp's (975 HK) operational numbers for Q2/H1 FY24 and highlight the catalysts we await in their H1FY24...

Sameer Taneja

Arvida Group - Takeover Offer Returns

Arvida Group's (ARV) board has unanimously recommended a NZ$1.70 per share takeover bid from Stonepeak, a US based infrastructure and real assets...

Forsyth Barr

Contact Energy - Steady End to FY24 - June '24 Operating Stats

Contact Energy (CEN) has had a steady end to FY24, with Tauhara commissioning volumes helping to offset below average hydro generation.

Forsyth Barr

Actinver Research - Housing Sector : Building a More Profitable Future (Sector Update)

The housing sector in Mexico has solid fundamentals, with attractive growth expectations for listed developers considering their healthy financial...

Actinver

Oneness Biotech partners with CR Double Crane for exclusive commercialization of Fespixon in China, Hong Kong, and Macau. Fespixon is approved in...